John W. Higuchi's most recent trade in Lipocine Inc was a trade of 1,764 Common Stock (Right to Buy) done . Disclosure was reported to the exchange on June 3, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Lipocine Inc | John W. Higuchi | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2026 | 1,764 | 13,290 | - | - | Common Stock (Right to Buy) | |
| Lipocine Inc | John W. Higuchi | Director | Purchase of securities on an exchange or from another person at price $ 2.03 per share. | 07 Apr 2026 | 40,000 | 203,797 (0%) | 0% | 2.0 | 81,200 | Common stock |
| Lipocine Inc | John W. Higuchi | Director | Purchase of securities on an exchange or from another person at price $ 2.05 per share. | 06 Apr 2026 | 123,000 | 163,797 (0%) | 0% | 2.1 | 252,150 | Common stock |
| Lipocine Inc | John W. Higuchi | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2025 | 1,764 | 11,526 | - | - | Common Stock (Right to Buy) | |
| Lipocine Inc | John W. Higuchi | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2024 | 1,764 | 10,938 | - | - | Common Stock (Right to Buy) | |
| Lipocine Inc | John W. Higuchi | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 May 2023 | 30,000 | 156,000 | - | - | Common Stock (Right to Buy) | |
| Lipocine Inc | John W. Higuchi | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2022 | 22,000 | 307,490 | - | - | Common Stock (Right to Buy) |